샘플 요청 목록

 카트 문의
시장보고서
상품코드
2042672

이비인후과 의료기기 시장 규모 및 예측(2021-2034년) : 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 - 제품별, 용도별, 최종사용자별, 지역별

ENT Devices Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography
발행일: | 리서치사: 구분자 The Insight Partners | 페이지 정보: 영문 419 Pages | 배송안내 : 즉시배송

    
    
    



가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.
US $ 4,450 금액 안내 화살표 ￦ 6,842,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,450 금액 안내 화살표 ￦ 9,918,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,450 금액 안내 화살표 ￦ 12,993,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

당사 새로운 조사 보고서 '이비인후과 의료기기 시장 예측(-2034년) - 제품, 용도, 최종사용자, 지역별 세계 분석'에 의하면, 이 시장은 2025년 229억 5,000만 달러에서 성장하여 2034년까지 379억 2,000만 달러에 이를 것으로 예측됩니다. 또한, 2026-2034년 CAGR 5.8%를 나타낼 전망입니다. 이비인후과(ENT) 의료기기 시장 성장은 이비인후과 질환 유병률 증가, 저침습인 이비인후과 수술 보급 확대, 의식의 고양, 원격의료 및 조기 스크리닝 대처가, 이비인후과 의료기기 채택을 촉진하고 있는 것에 기인하고 있습니다.

이비인후과 의료기기는 임상 현장에서 난청, 부비동 질환, 감염, 기도 이상 등 귀, 코, 목의 질환을 진단, 모니터링, 치료하는 데 사용됩니다. 이비인후과 질환 증가, 고령화, 의료비 증가, 저침습적 기술 개발, 의료 서비스 접근성 확대 등이 이비인후과 기기 시장의 성장을 견인하고 있습니다. 질병의 조기 발견 및 치료에 대한 대중의 인식이 높아지고, 최신 진단 및 수술 기기에 대한 수요가 증가하면서 이비인후과용 기기 시장 규모가 확대되고 있습니다.

북미 이비인후과용 기기 시장은 미국, 캐나다, 멕시코로 구분됩니다. 북미는 이비인후과 질환의 유병률 증가, 탄탄한 의료 인프라, 첨단 기술의 급속한 보급으로 이비인후과용 기기 시장을 주도하고 있습니다. 이 지역에서는 난청, 부비동염, 폐쇄성 수면무호흡증(OSA) 등 만성 이비인후과 질환으로 인한 부담이 크며, 이를 합치면 수백만 명에게 영향을 미치고 있습니다. 미국 난청협회(Hearing Loss Association of America)에 따르면, 2024년 기준 5,000만 명 이상의 미국인이 어느 정도의 난청을 앓고 있으며, 보청기와 인공와우는 이비인후과용 기기 시장에서 필수적인 요소로 자리 잡고 있습니다. 미국 및 캐나다 전역의 병원과 전문 이비인후과 클리닉에서는 환자의 치료 결과를 개선하고 입원 기간을 단축하기 위해 풍선 부비동 성형술 시스템 및 내시경 장비와 같은 최소 침습 수술용 장비를 점점 더 많이 도입하고 있습니다. 예를 들어, 만성 부비동염에 대한 풍선 부비동 성형술은 기존 수술에 비해 회복기간이 짧고 합병증도 적어 빠르게 보급되고 있습니다.

이 지역에서는 원격의료, AI를 활용한 진단 도구 등 디지털 헬스 기술 도입이 눈에 띄게 진행되고 있습니다. 원격의료의 도입으로 지리적 장벽을 극복하고 이비인후과 의료에 대한 접근성이 향상되었으며, 이명, 수면무호흡증과 같은 만성질환에 대한 경과관찰 진료도 개선되고 있습니다. 또한, 미국 식품의약국(FDA)과 같은 규제 당국의 지원은 혁신적인 이비인후과 기기 도입을 촉진하고 제조업체들이 이 분야의 연구개발에 많은 투자를 하도록 장려하고 있습니다.

북미에서 이비인후과용 기기 시장 점유율은 미국이 가장 큰 비중을 차지하고 있으며, 이는 높은 이비인후과 질환 유병률, 첨단 의료 인프라, 그리고 혁신적인 의료기술의 적극적인 도입에 힘입은 바 큽니다. 난청은 가장 흔한 만성 질환 중 하나입니다. 청각건강재단(Hearing Health Foundation)에 따르면, 2024년 기준 미국에서는 약 4,800만 명이 난청을 앓고 있는 것으로 나타났습니다. 이러한 광범위한 유병률은 보청기, 인공와우 및 청력 검사 장비에 대한 수요를 촉진하고 있으며, 이는 임상 현장과 재택 치료 환경 모두에 영향을 미치고 있습니다. 또한, 만성 부비동염이나 알레르기성 비염도 의료기관을 찾는 횟수를 크게 증가시키는 요인으로 작용하고 있습니다. University of Michigan Health의 보고서에 따르면, 미국에서는 3,100만 명이 만성 부비동염을 앓고 있으며, 연간 1,600만 건 이상의 외래 진료의 원인이 되고 있습니다. 이에 따라 비내시경, 풍선 부비동 성형술 키트와 같은 최소침습 수술 장비와 같은 첨단 진단 도구의 사용이 증가하고 있습니다. 이러한 장비를 통해 이비인후과 전문의는 기존 수술에 비해 회복 기간을 단축하면서 효과적인 외래 수술을 할 수 있게 되었습니다.

폐쇄성 수면무호흡증(OSA)도 이비인후과와 관련된 흔한 질환으로, 수면 모니터와 같은 진단 장비와 CPAP 장치, 고주파 절제 장치와 같은 치료 장비에 대한 수요를 창출하고 있습니다. 수면연구학회에 따르면, 2024년 기준 미국에서는 약 8,060만 명이 OSA를 앓고 있다고 합니다. 미국 시장은 미국 식품의약국(FDA)을 포함한 강력한 규제 프레임워크의 혜택을 받고 있으며, FDA는 최첨단 이비인후과용 기기의 승인을 적극적으로 추진하고 있습니다. 이로 인해 제조업체들은 AI를 활용한 이비인후과 검사, 로봇 보조 이비인후과 수술 플랫폼 등의 기술 혁신과 도입을 촉진하고 있습니다. 또한, 원격의료의 도입으로 특히 원격지나 의료서비스가 부족한 지역의 사람들에게 이비인후과 의료에 대한 접근성이 확대되고 있습니다.

인공지능(AI)과 머신러닝(ML)의 통합은 미래 시장 기회를 가져올 것입니다.

인공지능(AI)과 머신러닝(ML)을 이비인후과 기기에 통합하는 것은 이비인후과 시장에서 가장 혁신적인 미래 트렌드 중 하나로 떠오르고 있습니다. 이비인후과 질환의 유병률이 증가하고 조기 개입이 중요해짐에 따라 AI는 이러한 질환의 진단, 모니터링, 치료에 혁명을 일으키고 있습니다. AI를 활용한 진단 도구는 귀경, 내시경, CT 스캔의 이미지를 분석하여 중이염, 비용종, 종양 등의 이상 징후를 높은 정확도로 감지합니다. 예를 들어, 고막 영상을 분석해 소아 중이염이 세균성인지 바이러스성인지 구분하는 AI 알고리즘이 개발되어 불필요한 항생제 처방을 줄이고 치료 결과를 개선하고 있습니다. 또한, 보청기나 인공와우를 맞춤화하기 위한 보청기 및 인공와우 분야에서도 머신러닝이 점점 더 많이 활용되고 있습니다. AI가 탑재된 보청기는 사용자의 환경과 청취 선호도를 장기적으로 분석하여 소리 설정을 자동으로 조정하고, 배경 소음을 줄이며, 음성의 선명도를 높일 수 있습니다. 이는 안정적인 청력이 삶의 질에 필수적인 고령 사용자에게 특히 유용합니다. 또한, AI를 활용한 음성 인식 및 언어처리 도구가 인공와우 프로그래밍에 내장되어 있어 수술 후 환자에게 보다 맞춤화된 재활치료를 가능하게 하고 있습니다.

AI는 수면무호흡증 진단 및 치료에도 활용되고 있으며, 센서와 머신러닝 알고리즘을 탑재한 스마트 이비인후과 기기가 수면 패턴을 모니터링하고 무호흡을 감지하여 데이터에 기반한 치료법을 제안합니다. 예를 들어, 웨어러블 기기나 스마트 CPAP 대체 장비는 이비인후과 전문의에게 실시간 분석 데이터를 제공하여 보다 정확한 개입을 가능하게 합니다. 또한, AI는 영상 유도 내비게이션 시스템이나 로봇 보조 수술을 통해 복잡한 이비인후과 수술 중 외과의사를 돕습니다. 실시간 데이터 분석과 시각적 오버레이는 내이, 두개저 등 섬세한 구조를 다루는 수술의 정확도를 높이는 데 도움이 됩니다. 이러한 시스템은 머신러닝을 활용하여 수술 합병증을 예측하고, 과거 환자 데이터를 기반으로 최적의 접근법을 제안하는 것도 가능합니다. 따라서 이비인후과용 기기에 AI와 ML의 통합이 진행되어 향후 몇 년 동안 진단용 이비인후과 기기 및 수술 계획에서 표준화될 것으로 예상되며, 이는 이비인후과 기기 시장의 성장을 견인할 것으로 예측됩니다.

목차

제1장 주요 요약

제2장 이비인후과 의료기기 시장 전망

제3장 경쟁 구도

제4장 이비인후과 의료기기 시장 : 주요 업계 역학

제5장 이비인후과 의료기기 시장 : 세계 시장 분석

제6장 이비인후과 의료기기 시장 매출 분석 : 제품별

제7장 이비인후과 의료기기 시장 매출 분석 : 용도별

제8장 이비인후과 의료기기 시장 매출 분석 : 최종사용자별

제9장 이비인후과 의료기기 시장 : 지역별 분석

제10장 이비인후과 의료기기 시장 상황

제11장 기업 개요

제12장 부록

LSH 26.06.05

According to our new research study on "ENT Devices Market Forecast to 2034 -Global Analysis - by Product, Application, and End User, and Geography," the market is anticipated to grow from US$ 22.95 billion in 2025 and is projected to reach US$ 37.92 billion by 2034; it is expected to register a CAGR of 5.8% during 2026-2034. The ENT devices market growth is attributed to increasing prevalence of ENT disorders, rising adoption of minimally invasive ENT procedures, enhanced awareness, telemedicine, and early screening initiatives drive the adoption of ENT devices.

ENT devices are used to diagnose, monitor, and treat conditions of the ear, nose, and throat, including hearing loss, sinus disorders, infections, and airway abnormalities in clinical settings. Rising ENT disorder cases, a growing aging population, increasing healthcare expenditure, the development of minimally invasive technologies, and expanding access to healthcare services are driving the ENT devices market growth. Rising public awareness about early disease detection and treatment, together with heightened demand for modern diagnostic and surgical tools, are contributing to the rising ENT devices market size.

The ENT devices market in North America is segmented into the US, Canada, and Mexico. North America is leading the ENT devices market, driven by a combination of increasing prevalence of ENT disorders, well-established healthcare infrastructure, and rapid adoption of cutting-edge technologies. The region experiences a significant burden of chronic ENT conditions such as hearing loss, sinusitis, and obstructive sleep apnea (OSA), which collectively affect millions of individuals. According to the Hearing Loss Association of America, more than 50 million Americans are living with some degree of hearing loss in 2024, making hearing aids and cochlear implants essential components of the ENT devices market. Hospitals and specialized ENT clinics across the US and Canada are increasingly adopting minimally invasive surgical devices, such as balloon sinuplasty systems and endoscopic instruments, to improve patient outcomes and reduce hospital stays. For instance, balloon sinuplasty procedures for chronic sinusitis have grown rapidly, owing to shorter recovery times and reduced complications compared to traditional surgery.

The region is witnessing significant integration of digital health technologies, including telemedicine and AI-powered diagnostic tools. Telehealth adoption has enhanced access to ENT care, overcoming geographical barriers and improving follow-up care for chronic conditions such as tinnitus and sleep apnea. Additionally, regulatory support from agencies such as the US Food and Drug Administration (FDA) facilitates the introduction of innovative ENT devices, encouraging manufacturers to invest heavily in research and development within this region.

The US holds the largest market share of ENT devices in North America, driven by a high prevalence of ENT disorders, advanced healthcare infrastructure, and strong adoption of innovative medical technologies. Hearing loss is among the most common chronic conditions. As per the Hearing Health Foundation, ~48 million people in the US were living with hearing loss in 2024. This widespread prevalence fuels demand for hearing aids, cochlear implants, and diagnostic audiometry devices across clinical and home care settings. Additionally, chronic sinusitis and allergic rhinitis also significantly contribute to healthcare visits. According to the University of Michigan Health report, chronic sinusitis affects 31 million people in the US, and it accounts for more than 16 million outpatient visits in a year. This has increased the use of advanced diagnostic tools such as nasal endoscopes and minimally invasive surgical devices such as balloon sinuplasty kits. These devices allow ENT specialists to perform effective, outpatient procedures with reduced recovery times compared to traditional surgeries.

Obstructive sleep apnea (OSA) is another prevalent ENT-related condition, creating the demand for diagnostic devices such as sleep monitors and therapeutic equipment, including CPAP machines and radiofrequency ablation tools. As per the Sleep Research Society, ~80.6 million people are affected by OSA in the US in 2024. The US market benefits from robust regulatory frameworks, including the US Food and Drug Administration (FDA), which actively facilitates the approval of cutting-edge ENT devices. This encourages manufacturers to innovate and introduce technologies such as AI-powered otoscopy and robotic-assisted ENT surgery platforms. Additionally, the integration of telemedicine has expanded access to ENT care, particularly for remote or underserved populations.

Integration of Artificial Intelligence (AI) And Machine Learning (ML) to Provide Market Opportunities in Future

The integration of Artificial Intelligence (AI) and Machine Learning (ML) into ENT devices is emerging as one of the most transformative future trends in the ENT devices market. As ENT disorders become more prevalent and early intervention becomes critical, AI is helping to revolutionize the diagnosis, monitoring, and treatment of such conditions. AI-powered diagnostic tools analyze images from otoscopes, endoscopes, and CT scans to detect abnormalities such as ear infections, nasal polyps, or tumors with a high degree of accuracy. For instance, AI algorithms are being developed to distinguish between bacterial and viral otitis media in children by analyzing tympanic membrane images, reducing unnecessary antibiotic prescriptions, and improving treatment outcomes. Additionally, machine learning is increasingly used for hearing care to customize hearing aids and cochlear implants. By analyzing user environments and listening preferences over time, AI-enabled hearing aids can automatically adjust sound settings, filter background noise, and enhance speech clarity. This especially benefits elderly users, for whom consistent hearing is essential to well-being. Additionally, AI-driven speech recognition and language processing tools are integrated into cochlear implant programming, enabling more personalized rehabilitation therapy for post-implant patients.

AI is also used in sleep apnea diagnosis and treatment, where smart ENT devices with sensors and machine learning algorithms monitor sleep patterns, detect apneas, and offer data-driven treatment suggestions. For instance, wearable devices or smart CPAP alternatives can provide ENT specialists with real-time analytics, enabling more targeted interventions. Furthermore, AI assists surgeons during complex ENT procedures through image-guided navigation systems and robotic-assisted surgeries. Real-time data analysis and visual overlays help improve precision in procedures involving delicate structures such as the inner ear or skull base. These systems can also use machine learning to predict surgical complications or suggest optimal approaches based on historical patient data. Therefore, increasing integration of AI and ML in the ENT devices is expected to become standard in diagnostic ENT devices and procedural planning in the coming years, which is expected to drive the growth of the ENT devices market.

The US Food and Drug Administration, The European Hearing Instrument Manufacturers Association, Academy advocates for otolaryngology, The Association for Research in Otolaryngology, Association for the Global Advancement of ENT are among the primary and secondary sources referred to while preparing the ENT devices market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. ENT Devices Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
    • 2.2.1 Raw Material Suppliers / Components
    • 2.2.2 Manufacturers Process / Technology
    • 2.2.3 Distribution Landscape
    • 2.2.4 End-User
    • 2.2.5 Level of Integration
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 Porter's Five Force Analysis
    • 2.4.1 Threat of New Entrants
    • 2.4.2 Threat of Substitutes
    • 2.4.3 Bargaining Power of Buyers
    • 2.4.4 Bargaining Power of Suppliers
    • 2.4.5 Competitive Rivalry
  • 2.5 PEST Analysis
  • 2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
    • 2.6.1 Import-Export Analysis for Key Countries (Value)- Product: 901890 Instruments and appliances used in medical, surgical or veterinary sciences, n.e.s.
    • 2.6.2 Import-Export Analysis for Key Countries (Volume)
  • 2.7 Impact of Artificial Intelligence (AI)
    • 2.7.1 Enhanced Diagnostic Precision
    • 2.7.2 Smart Hearing and Implantable Solutions
    • 2.7.3 Surgical Precision and Robotics
    • 2.7.4 Predictive Analytics and Remote Monitoring
  • 2.8 Product or Technology Roadmap
  • 2.9 Sustainability and ESG Trends
  • 2.10 Regulatory Framework
  • 2.11 Balloon Eustachian Tube Dilation Devices Market
  • 2.12 Epistaxis Management Devices Market

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis, 2025 - By Key Players
  • 3.3 Market Concentration

4. ENT Devices Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Prevalence of ENT Disorders
    • 4.1.2 Increasing Adoption of Minimally Invasive ENT Procedures
    • 4.1.3 Enhanced Awareness, Telemedicine, and Early Screening Initiatives
  • 4.2 Market Restraints
    • 4.2.1 High Costs of ENT Devices
    • 4.2.2 Stringent Regulatory Requirements and Prolonged Approval Processes
    • 4.2.3 Inadequate Reimbursement Policies and Insurance Coverage Gaps
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives by Market Players
    • 4.3.2 Integration of Artificial Intelligence and Machine Learning in ENT Diagnostics and Treatment
    • 4.3.3 Accelerated Adoption of Telemedicine and Remote Monitoring in ENT Care
  • 4.4 Future Trends
    • 4.4.1 Deep Integration of Artificial Intelligence for Predictive and Personalized ENT Interventions
    • 4.4.2 Proliferation of 3D Bioprinting for Custom Regenerative ENT Constructs
    • 4.4.3 Rise of Biohybrid and Stem Cell-Infused Regenerative ENT Implants
  • 4.5 Impact of Drivers and Restraints

5. ENT Devices Market - Global Market Analysis

  • 5.1 ENT Devices Market Revenue (US$ Million), 2021-2034
  • 5.2 ENT Devices Market Forecast and Analysis

6. ENT Devices Market Revenue Analysis - Product

  • 6.1 ENT Devices Market Forecasts and Analysis by Product
    • 6.1.1 Diagnostic ENT Devices
      • 6.1.1.1 Overview
      • 6.1.1.2 Diagnostic ENT Devices: ENT Devices Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.2 Surgical ENT Devices
      • 6.1.2.1 Overview
      • 6.1.2.2 Surgical ENT Devices: ENT Devices Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.3 Therapeutic ENT Devices
      • 6.1.3.1 Overview
      • 6.1.3.2 Therapeutic ENT Devices: ENT Devices Market - Revenue, 2021-2034 (US$ Million)

7. ENT Devices Market Revenue Analysis - Application

  • 7.1 ENT Devices Market Forecasts and Analysis by Application
    • 7.1.1 Otology
      • 7.1.1.1 Overview
      • 7.1.1.2 Otology: ENT Devices Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.2 Rhinology
      • 7.1.2.1 Overview
      • 7.1.2.2 Rhinology: ENT Devices Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.3 Laryngology
      • 7.1.3.1 Overview
      • 7.1.3.2 Laryngology: ENT Devices Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.4 Other Applications
      • 7.1.4.1 Overview
      • 7.1.4.2 Other Applications: ENT Devices Market - Revenue, 2021-2034 (US$ Million)

8. ENT Devices Market Revenue Analysis - End User

  • 8.1 ENT Devices Market Forecasts and Analysis by End User
    • 8.1.1 Hospitals
      • 8.1.1.1 Overview
      • 8.1.1.2 Hospitals: ENT Devices Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.2 Ambulatory Surgical Centers (ASC)
      • 8.1.2.1 Overview
      • 8.1.2.2 Ambulatory Surgical Centers (ASC): ENT Devices Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.3 ENT Specialty Clinics
      • 8.1.3.1 Overview
      • 8.1.3.2 ENT Specialty Clinics: ENT Devices Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.4 Home Healthcare
      • 8.1.4.1 Overview
      • 8.1.4.2 Home Healthcare: ENT Devices Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.5 Other End Users
      • 8.1.5.1 Overview
      • 8.1.5.2 Other End Users: ENT Devices Market - Revenue, 2021-2034 (US$ Million)

9. ENT Devices Market - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America ENT Devices Market Overview
    • 9.1.2 North America: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 9.1.3 North America: ENT Devices Market - By Segmentation
      • 9.1.3.1 Product
      • 9.1.3.2 Diagnostic ENT Devices For Product
      • 9.1.3.3 ENT Endoscopes For Diagnostic ENT Devices
      • 9.1.3.4 Surgical ENT Devices For Product
      • 9.1.3.5 Balloon Dilation Devices For Surgical ENT Devices
      • 9.1.3.6 Therapeutic ENT Devices For Product
      • 9.1.3.7 Application
      • 9.1.3.8 End User
    • 9.1.4 North America: ENT Devices Market Breakdown by Countries
      • 9.1.4.1 United States Market
        • 9.1.4.1.1 United States: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.1.4.1.2 United States: ENT Devices Market - By Segmentation
          • 9.1.4.1.2.1 Product
          • 9.1.4.1.2.2 Diagnostic ENT Devices For Product
          • 9.1.4.1.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.1.4.1.2.4 Surgical ENT Devices For Product
          • 9.1.4.1.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.1.4.1.2.6 Therapeutic ENT Devices For Product
          • 9.1.4.1.2.7 Application
          • 9.1.4.1.2.8 End User
      • 9.1.4.2 Canada Market
        • 9.1.4.2.1 Canada: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.1.4.2.2 Canada: ENT Devices Market - By Segmentation
          • 9.1.4.2.2.1 Product
          • 9.1.4.2.2.2 Diagnostic ENT Devices For Product
          • 9.1.4.2.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.1.4.2.2.4 Surgical ENT Devices For Product
          • 9.1.4.2.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.1.4.2.2.6 Therapeutic ENT Devices For Product
          • 9.1.4.2.2.7 Application
          • 9.1.4.2.2.8 End User
      • 9.1.4.3 Mexico Market
        • 9.1.4.3.1 Mexico: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.1.4.3.2 Mexico: ENT Devices Market - By Segmentation
          • 9.1.4.3.2.1 Product
          • 9.1.4.3.2.2 Diagnostic ENT Devices For Product
          • 9.1.4.3.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.1.4.3.2.4 Surgical ENT Devices For Product
          • 9.1.4.3.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.1.4.3.2.6 Therapeutic ENT Devices For Product
          • 9.1.4.3.2.7 Application
          • 9.1.4.3.2.8 End User
  • 9.2 Europe
    • 9.2.1 Europe ENT Devices Market Overview
    • 9.2.2 Europe: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 9.2.3 Europe: ENT Devices Market - By Segmentation
      • 9.2.3.1 Product
      • 9.2.3.2 Diagnostic ENT Devices For Product
      • 9.2.3.3 ENT Endoscopes For Diagnostic ENT Devices
      • 9.2.3.4 Surgical ENT Devices For Product
      • 9.2.3.5 Balloon Dilation Devices For Surgical ENT Devices
      • 9.2.3.6 Therapeutic ENT Devices For Product
      • 9.2.3.7 Application
      • 9.2.3.8 End User
    • 9.2.4 Europe: ENT Devices Market Breakdown by Countries
      • 9.2.4.1 Germany Market
        • 9.2.4.1.1 Germany: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.1.2 Germany: ENT Devices Market - By Segmentation
          • 9.2.4.1.2.1 Product
          • 9.2.4.1.2.2 Diagnostic ENT Devices For Product
          • 9.2.4.1.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.2.4.1.2.4 Surgical ENT Devices For Product
          • 9.2.4.1.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.2.4.1.2.6 Therapeutic ENT Devices For Product
          • 9.2.4.1.2.7 Application
          • 9.2.4.1.2.8 End User
      • 9.2.4.2 United Kingdom Market
        • 9.2.4.2.1 United Kingdom: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.2.2 United Kingdom: ENT Devices Market - By Segmentation
          • 9.2.4.2.2.1 Product
          • 9.2.4.2.2.2 Diagnostic ENT Devices For Product
          • 9.2.4.2.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.2.4.2.2.4 Surgical ENT Devices For Product
          • 9.2.4.2.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.2.4.2.2.6 Therapeutic ENT Devices For Product
          • 9.2.4.2.2.7 Application
          • 9.2.4.2.2.8 End User
      • 9.2.4.3 France Market
        • 9.2.4.3.1 France: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.3.2 France: ENT Devices Market - By Segmentation
          • 9.2.4.3.2.1 Product
          • 9.2.4.3.2.2 Diagnostic ENT Devices For Product
          • 9.2.4.3.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.2.4.3.2.4 Surgical ENT Devices For Product
          • 9.2.4.3.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.2.4.3.2.6 Therapeutic ENT Devices For Product
          • 9.2.4.3.2.7 Application
          • 9.2.4.3.2.8 End User
      • 9.2.4.4 Italy Market
        • 9.2.4.4.1 Italy: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.4.2 Italy: ENT Devices Market - By Segmentation
          • 9.2.4.4.2.1 Product
          • 9.2.4.4.2.2 Diagnostic ENT Devices For Product
          • 9.2.4.4.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.2.4.4.2.4 Surgical ENT Devices For Product
          • 9.2.4.4.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.2.4.4.2.6 Therapeutic ENT Devices For Product
          • 9.2.4.4.2.7 Application
          • 9.2.4.4.2.8 End User
      • 9.2.4.5 Spain Market
        • 9.2.4.5.1 Spain: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.5.2 Spain: ENT Devices Market - By Segmentation
          • 9.2.4.5.2.1 Product
          • 9.2.4.5.2.2 Diagnostic ENT Devices For Product
          • 9.2.4.5.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.2.4.5.2.4 Surgical ENT Devices For Product
          • 9.2.4.5.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.2.4.5.2.6 Therapeutic ENT Devices For Product
          • 9.2.4.5.2.7 Application
          • 9.2.4.5.2.8 End User
      • 9.2.4.6 Rest of Europe Market
        • 9.2.4.6.1 Rest of Europe: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.2.4.6.2 Rest of Europe: ENT Devices Market - By Segmentation
          • 9.2.4.6.2.1 Product
          • 9.2.4.6.2.2 Diagnostic ENT Devices For Product
          • 9.2.4.6.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.2.4.6.2.4 Surgical ENT Devices For Product
          • 9.2.4.6.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.2.4.6.2.6 Therapeutic ENT Devices For Product
          • 9.2.4.6.2.7 Application
          • 9.2.4.6.2.8 End User
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific ENT Devices Market Overview
    • 9.3.2 Asia Pacific: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 9.3.3 Asia Pacific: ENT Devices Market - By Segmentation
      • 9.3.3.1 Product
      • 9.3.3.2 Diagnostic ENT Devices For Product
      • 9.3.3.3 ENT Endoscopes For Diagnostic ENT Devices
      • 9.3.3.4 Surgical ENT Devices For Product
      • 9.3.3.5 Balloon Dilation Devices For Surgical ENT Devices
      • 9.3.3.6 Therapeutic ENT Devices For Product
      • 9.3.3.7 Application
      • 9.3.3.8 End User
    • 9.3.4 Asia Pacific: ENT Devices Market Breakdown by Countries
      • 9.3.4.1 China Market
        • 9.3.4.1.1 China: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.3.4.1.2 China: ENT Devices Market - By Segmentation
          • 9.3.4.1.2.1 Product
          • 9.3.4.1.2.2 Diagnostic ENT Devices For Product
          • 9.3.4.1.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.3.4.1.2.4 Surgical ENT Devices For Product
          • 9.3.4.1.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.3.4.1.2.6 Therapeutic ENT Devices For Product
          • 9.3.4.1.2.7 Application
          • 9.3.4.1.2.8 End User
      • 9.3.4.2 Japan Market
        • 9.3.4.2.1 Japan: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.3.4.2.2 Japan: ENT Devices Market - By Segmentation
          • 9.3.4.2.2.1 Product
          • 9.3.4.2.2.2 Diagnostic ENT Devices For Product
          • 9.3.4.2.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.3.4.2.2.4 Surgical ENT Devices For Product
          • 9.3.4.2.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.3.4.2.2.6 Therapeutic ENT Devices For Product
          • 9.3.4.2.2.7 Application
          • 9.3.4.2.2.8 End User
      • 9.3.4.3 India Market
        • 9.3.4.3.1 India: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.3.4.3.2 India: ENT Devices Market - By Segmentation
          • 9.3.4.3.2.1 Product
          • 9.3.4.3.2.2 Diagnostic ENT Devices For Product
          • 9.3.4.3.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.3.4.3.2.4 Surgical ENT Devices For Product
          • 9.3.4.3.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.3.4.3.2.6 Therapeutic ENT Devices For Product
          • 9.3.4.3.2.7 Application
          • 9.3.4.3.2.8 End User
      • 9.3.4.4 Australia Market
        • 9.3.4.4.1 Australia: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.3.4.4.2 Australia: ENT Devices Market - By Segmentation
          • 9.3.4.4.2.1 Product
          • 9.3.4.4.2.2 Diagnostic ENT Devices For Product
          • 9.3.4.4.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.3.4.4.2.4 Surgical ENT Devices For Product
          • 9.3.4.4.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.3.4.4.2.6 Therapeutic ENT Devices For Product
          • 9.3.4.4.2.7 Application
          • 9.3.4.4.2.8 End User
      • 9.3.4.5 South Korea Market
        • 9.3.4.5.1 South Korea: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.3.4.5.2 South Korea: ENT Devices Market - By Segmentation
          • 9.3.4.5.2.1 Product
          • 9.3.4.5.2.2 Diagnostic ENT Devices For Product
          • 9.3.4.5.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.3.4.5.2.4 Surgical ENT Devices For Product
          • 9.3.4.5.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.3.4.5.2.6 Therapeutic ENT Devices For Product
          • 9.3.4.5.2.7 Application
          • 9.3.4.5.2.8 End User
      • 9.3.4.6 Rest of APAC Market
        • 9.3.4.6.1 Rest of APAC: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.3.4.6.2 Rest of APAC: ENT Devices Market - By Segmentation
          • 9.3.4.6.2.1 Product
          • 9.3.4.6.2.2 Diagnostic ENT Devices For Product
          • 9.3.4.6.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.3.4.6.2.4 Surgical ENT Devices For Product
          • 9.3.4.6.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.3.4.6.2.6 Therapeutic ENT Devices For Product
          • 9.3.4.6.2.7 Application
          • 9.3.4.6.2.8 End User
  • 9.4 Middle East and Africa
    • 9.4.1 Middle East and Africa ENT Devices Market Overview
    • 9.4.2 Middle East and Africa: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 9.4.3 Middle East and Africa: ENT Devices Market - By Segmentation
      • 9.4.3.1 Product
      • 9.4.3.2 Diagnostic ENT Devices For Product
      • 9.4.3.3 ENT Endoscopes For Diagnostic ENT Devices
      • 9.4.3.4 Surgical ENT Devices For Product
      • 9.4.3.5 Balloon Dilation Devices For Surgical ENT Devices
      • 9.4.3.6 Therapeutic ENT Devices For Product
      • 9.4.3.7 Application
      • 9.4.3.8 End User
    • 9.4.4 Middle East and Africa: ENT Devices Market Breakdown by Countries
      • 9.4.4.1 Saudi Arabia Market
        • 9.4.4.1.1 Saudi Arabia: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.4.4.1.2 Saudi Arabia: ENT Devices Market - By Segmentation
          • 9.4.4.1.2.1 Product
          • 9.4.4.1.2.2 Diagnostic ENT Devices For Product
          • 9.4.4.1.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.4.4.1.2.4 Surgical ENT Devices For Product
          • 9.4.4.1.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.4.4.1.2.6 Therapeutic ENT Devices For Product
          • 9.4.4.1.2.7 Application
          • 9.4.4.1.2.8 End User
      • 9.4.4.2 South Africa Market
        • 9.4.4.2.1 South Africa: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.4.4.2.2 South Africa: ENT Devices Market - By Segmentation
          • 9.4.4.2.2.1 Product
          • 9.4.4.2.2.2 Diagnostic ENT Devices For Product
          • 9.4.4.2.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.4.4.2.2.4 Surgical ENT Devices For Product
          • 9.4.4.2.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.4.4.2.2.6 Therapeutic ENT Devices For Product
          • 9.4.4.2.2.7 Application
          • 9.4.4.2.2.8 End User
      • 9.4.4.3 United Arab Emirates Market
        • 9.4.4.3.1 United Arab Emirates: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.4.4.3.2 United Arab Emirates: ENT Devices Market - By Segmentation
          • 9.4.4.3.2.1 Product
          • 9.4.4.3.2.2 Diagnostic ENT Devices For Product
          • 9.4.4.3.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.4.4.3.2.4 Surgical ENT Devices For Product
          • 9.4.4.3.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.4.4.3.2.6 Therapeutic ENT Devices For Product
          • 9.4.4.3.2.7 Application
          • 9.4.4.3.2.8 End User
      • 9.4.4.4 Rest of Middle East and Africa Market
        • 9.4.4.4.1 Rest of Middle East and Africa: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.4.4.4.2 Rest of Middle East and Africa: ENT Devices Market - By Segmentation
          • 9.4.4.4.2.1 Product
          • 9.4.4.4.2.2 Diagnostic ENT Devices For Product
          • 9.4.4.4.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.4.4.4.2.4 Surgical ENT Devices For Product
          • 9.4.4.4.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.4.4.4.2.6 Therapeutic ENT Devices For Product
          • 9.4.4.4.2.7 Application
          • 9.4.4.4.2.8 End User
  • 9.5 South and Central America
    • 9.5.1 South and Central America ENT Devices Market Overview
    • 9.5.2 South and Central America: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 9.5.3 South and Central America: ENT Devices Market - By Segmentation
      • 9.5.3.1 Product
      • 9.5.3.2 Diagnostic ENT Devices For Product
      • 9.5.3.3 ENT Endoscopes For Diagnostic ENT Devices
      • 9.5.3.4 Surgical ENT Devices For Product
      • 9.5.3.5 Balloon Dilation Devices For Surgical ENT Devices
      • 9.5.3.6 Therapeutic ENT Devices For Product
      • 9.5.3.7 Application
      • 9.5.3.8 End User
    • 9.5.4 South and Central America: ENT Devices Market Breakdown by Countries
      • 9.5.4.1 Brazil Market
        • 9.5.4.1.1 Brazil: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.5.4.1.2 Brazil: ENT Devices Market - By Segmentation
          • 9.5.4.1.2.1 Product
          • 9.5.4.1.2.2 Diagnostic ENT Devices For Product
          • 9.5.4.1.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.5.4.1.2.4 Surgical ENT Devices For Product
          • 9.5.4.1.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.5.4.1.2.6 Therapeutic ENT Devices For Product
          • 9.5.4.1.2.7 Application
          • 9.5.4.1.2.8 End User
      • 9.5.4.2 Argentina Market
        • 9.5.4.2.1 Argentina: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.5.4.2.2 Argentina: ENT Devices Market - By Segmentation
          • 9.5.4.2.2.1 Product
          • 9.5.4.2.2.2 Diagnostic ENT Devices For Product
          • 9.5.4.2.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.5.4.2.2.4 Surgical ENT Devices For Product
          • 9.5.4.2.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.5.4.2.2.6 Therapeutic ENT Devices For Product
          • 9.5.4.2.2.7 Application
          • 9.5.4.2.2.8 End User
      • 9.5.4.3 Rest of South and Central America Market
        • 9.5.4.3.1 Rest of South and Central America: ENT Devices Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 9.5.4.3.2 Rest of South and Central America: ENT Devices Market - By Segmentation
          • 9.5.4.3.2.1 Product
          • 9.5.4.3.2.2 Diagnostic ENT Devices For Product
          • 9.5.4.3.2.3 ENT Endoscopes For Diagnostic ENT Devices
          • 9.5.4.3.2.4 Surgical ENT Devices For Product
          • 9.5.4.3.2.5 Balloon Dilation Devices For Surgical ENT Devices
          • 9.5.4.3.2.6 Therapeutic ENT Devices For Product
          • 9.5.4.3.2.7 Application
          • 9.5.4.3.2.8 End User

10. ENT Devices Market Industry Landscape

11. Company Profiles

  • 11.1 Olympus Corp
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Stryker Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Medtronic Plc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Meril Life Sciences Pvt Ltd
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Narang Medical Limited.
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Ambu A/S
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 MED-EL Medical Electronics
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Naugra Medical Lab
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Innovia Medical
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Poba Medical
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 Glossary
  • 12.2 Research Methodology and Approach
    • 12.2.1 Secondary Research
    • 12.2.2 Primary Research
    • 12.2.3 Market Estimation Approach
      • 12.2.3.1 Supply Side Analysis
      • 12.2.3.2 Demand Side Analysis
    • 12.2.4 Research Assumptions and Limitations
    • 12.2.5 Currency Conversion
  • 12.3 About The Insight Partners
  • 12.4 Market Intelligence Cloud
×

원하시는 정보를 찾아 드릴까요?

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기